Virus Filtration Market Size, Share, Growth, Trends & Analysis 2025
바이러스 여과는 여러 생물학 분야에 적용되는 효과적인 바이러스 제거 기술입니다. 세계 바이러스 여과 시장은 2017년 21억 3940만 달러에서 2025년 55억 5554만 달러에 이를 것으로 예상된다. 시장은 2018년부터 2025년까지 연평균 성장률(CAGR) 13.0%로 성장할 것으로 예상된다.
최근 만성질환의 증가로 인해 바이오의약품 산업이 급속도로 성장하고 있습니다. 소분자와 달리 생물학적 약물은 동물, 식물 및 합성 원료를 혼합하여 제조됩니다. 일부 생물학적 치료 제품은 포유류 세포주나 인간 혈장을 사용하여 생산됩니다. 이들 모두는 오염 가능성을 10배 증가시킵니다. 이러한 제품은 바이러스에 오염될 위험이 있습니다. 따라서 규제 기관은 제조업체가 바이러스 오염 위험을 평가하고 이를 완화하기 위해 필요한 조치를 취하도록 의무화했습니다. 바이러스 여과 시장은 위험을 피하고 규제 기관이 정한 안전 기준을 준수하기 위해 바이오의약품의 정제에 광범위하게 사용됩니다. 제약회사들은 바이러스 여과가 바이오의약품의 안전성에 중요한 역할을 하게 되므로 이에 대한 투자를 늘렸습니다.
실험실에서 바이러스는 공기, 물, 테스트 샘플을 쉽게 오염시킵니다. 따라서 바이러스 여과가 필수적입니다. 연속 바이오프로세싱은 mAb 생산에서 빠르게 추진력을 얻고 있으며, 더 작은 시설 설치 공간, 더 낮은 투자 비용, 유연성 및 공정 경제성과 같은 잠재적인 이점을 제공합니다. 지속적인 다운스트림 처리는 이 과정에서 바이러스 여과에 의존합니다. 바이러스 여과 시장 방식은 막 장벽을 사용하여 바이러스 입자를 유지하여 오염 없는 환경을 유지합니다. 이는 다양한 최종 사용자 분야에서 사용되는 강력하고 신뢰할 수 있는 바이러스 제거 기술입니다. 글로벌 바이러스 여과 시장 성장은 생물의약품 및 바이오의약품 제조 증가, 엄격한 규제 기준, R&D 및 아웃소싱 활동에 대한 투자 증가에 의해 주도됩니다.
드라이버
제약 및 생명공학 산업의 급속한 성장
지난 몇 년간 제약 산업은 엄청난 발전을 이루었습니다. 신약, 첨단 치료법, 급속한 디지털화, 변화하는 규제에 대한 수요는 제조업체와 계약 연구 기관(CRO) 에게 의료 문제를 제기합니다 . 세계보건기구(WHO)에 따르면 전 세계 인구는 매년 1.24%씩 증가하고 있으며 이로 인해 의약품과 의약품에 대한 과잉 수요가 발생하고 있습니다. 제약 산업은 2017년까지 이전 추정치보다 30% 더 성장하여 상위 5대 산업 중 위치를 유지하고 글로벌 경제적 가치를 더했습니다. 몇몇 제약 제조업체는 개발도상국의 중산층 인구에 맞는 저렴한 의약품을 생산합니다. 모든 새로운 약물 제제에는 알려지거나 알려지지 않은 바이러스 흔적의 제거를 평가하기 위한 필수 바이러스 제거 테스트가 제공됩니다.
엄격한 규제 프레임워크
식품의약청(FDA), 유럽의약청(EMA) 등 주요 규제 당국은 제약 및 생명공학 산업의 발전을 지속적으로 추적하고 모니터링합니다. 제조업체는 현행 우수 제조 관리 기준(GMP) 및 우수 실험실 관리 기준(GLP)을 따르기 위해 업데이트된 규정을 준수합니다. 규정된 프로토콜에서 벗어나는 경우 해당 제조업체 또는 외주 기관의 임상 시험이 종료될 수 있습니다. 미국 FDA는 인간 세포주 또는 동물 유래 제품의 바이러스 안전성 평가와 관련하여 제약 회사를 위한 지침을 발표했습니다. 의료 관리 기관이 시행하는 이러한 엄격한 규정은 약물 개발 과정에서 바이러스 제거 테스트를 의무화합니다.
구속
바이러스 제거를 위한 대체 기술의 가용성
외래성 바이러스 제제는 생물학적 의약품 생산 시 고유한 오염 위험을 가지고 있습니다. 규제 기관은 이미 이러한 문제를 사전에 해결했습니다. 바이러스 여과의 성공 여부는 적합한 방법에 대한 선호도에 달려 있습니다. 적절한 방법은 다양한 생물학적, 임상적 요인의 함수입니다. 몇 가지 주요 방법으로는 낮은 pH 완충액 추가, 온도 유지, 생물학적 처리 용액에서 바이러스를 비활성화하는 세제 처리 등이 있습니다. 이러한 실행 가능한 방법 중에서 바이러스 여과 기술은 고압멸균을 통해 용액을 멸균할 수 없는 경우에만 배포됩니다. 이는 여과 요구 사항을 중단하여 글로벌 바이러스 여과 시장의 성장을 방해합니다.
귀하의 요구 사항에 맞게 연구를 맞춤화하십시오
우리는 표준 제품을 통해 충족되지 않는 분석과 범위를 최적화하고 조정할 수 있습니다. 이러한 유연성은 비즈니스 계획 및 의사 결정에 필요한 정확한 정보를 얻는 데 도움이 됩니다.
바이러스 여과 시장:
CAGR(2017~2025)13.0%- Market Size 2017
US$ 2.14 Billion - Market Size 2025
US$ 5.56 Billion
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Merck KGaA
- Sartorius AG
- Danaher (Pall Corporation)
- Thermo Fisher Scientific, Inc.
- General Electric
- Charles River
- Wuxi Apptec
- Lonza
- Asahi Kesai Corporation
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
- Filtration Systems
- Kits & Reagents
- Services
- Others
- Biologics
- Medical Devices
- Water Purification
- Air Purification
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Medical Device Companies
- Academic Research Institutes
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Market Segmentation
By Product
High Degree of Filtration in Biopharmaceutical Processes Support the Segmental Dominance
Based on product, the global virus filtration market is split into filtration systems, kits and reagents, services, and others. Among these, the kits and reagents segment occupied a notable market share in 2017. During lab-scale testing and biopharmaceutical manufacturing, kits and reagents effectively remove viruses from recombinant proteins, monoclonal antibodies, and tissue extracts. The ready-to-use commercial kits are specially used for viral DNA purification, qPCR, and immunological applications. The membranes of these kits are designed to remove viruses of specific sizes from aqueous solutions and substrates. Notably, the kits and reagents are easy and safe with little expertise and simple protocol.
The filtration systems segment was the second-largest occupant of the global virus filtration market in 2017. These filtration systems are generally used to remove parvoviruses or other specific types containing a protein coat. Filtration systems are advantageous over other virus removal techniques as they do not denature the samples' proteins. Moreover, these systems help increase the total throughput and slay down the overall virus filtration costs. As a result, they are being enormously adopted in medical device manufacturing and formulating research procedures.
By Application
Pharmaceutical Companies Conducting Several Clinical Tests Fuel the Segment’s Market Share
According to the application, the virus filtration market domain is split into biologics, medical devices, water purification, and air purification. Among these, the biologics segment led the market in 2017, with the largest revenue share. Under biological treatment therapies, a few substances are either naturally available in the body or cultivated in laboratories. These processes involve several instances leading to viral contamination. Hence, virus safety associated with plasma-derived therapeutics is assessed through virus clearance tests before submitting test results to regulatory bodies. All the pharmaceutical companies and CROs conducting the tests for clinical trials are expected to enhance the growth of the concerned segment over the coming years.
The water purification segment is anticipated to expand considerably throughout the forecast period. Enteric viruses in water can pose severe health hazards to humans and animals. They are highly resistant to the aquatic environment and cause water contamination. Filtration is a cost-effective and lucid method that produces excellent disinfection and prevents viruses from thriving in the water. It also becomes essential to purify the virus antigen from culture media that includes high volumes of water. Elimination of viral bodies from the water leads to optimum vaccination results.
Regional market
North America is the largest market for virus filtration, with the US holding the largest market share, followed by Canada. Biopharmaceutical and biotechnology companies, key market players, and various academic and research institutes have raised the demand for virus filtration systems, further stimulating the growth of North America's global virus filtration market.
Europe occupies a significant position in the global virus filtration market and is expected to register a robust growth rate owing to government and private funding for research in biologics and pharmaceuticals. Additionally, the launch of innovative technologies is likely to be the major factor driving the growth of this market in Europe. Germany is the biggest hub for biotechnology worldwide in Europe, owing to the presence of large biotech players, high-tech research labs, and massive funding for research and development.
Many developments have been witnessed in Europe and North America. This is the probable reason the market is expected to do so well in these regions during the prediction period.
Increasing research centers and government funding in Asia Pacific fuel the market's growth in the region. The government bodies provide grants to increase the participation of young researchers.
The Middle East & Africa consist of three major countries: United Arab Emirates (UAE), Saudi Arabia, and South Africa. The market in this region is driven by extensive research projects undertaken by several research institutes and the availability of infrastructure, as well as facilities for research. Government initiatives toward research and development, healthcare, and the availability of technologically advanced devices fuel the virus filtration market's growth.The South & Central America virus filtration market has grown due to recent technological developments. The low-cost advantage and higher work efficiency are the major attracting points for manufacturing companies to establish bases in South America.
Key Market Players:
- MERCK KGAA (Germany)
- Sartorius AG (Germany)
- Danaher (Pall Corporation) (US)
- Thermo Fisher Scientific Inc (US)
- General Electric (US)
- Charles River (US)
- Wuxi Apptec (China)
- Lonza (Switzerland)
- Asahi Kasei Corporation (Japan)
- Clean Cells (France)
Virus Filtration Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2017 | US$ 2.14 Billion |
Market Size by 2025 | US$ 5.56 Billion |
Global CAGR (2017 - 2025) | 13.0% |
Historical Data | 2015-2016 |
Forecast period | 2018-2025 |
Segments Covered | By Virus Filtration Market - Global Analysis and Forecast - by Product
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Key Developments:
- February 2018: Merck launched Viresolve Barrier capsule filters to reduce bioreactor contamination risk. These capsules remove viruses, mycoplasma, and bacteria from cell culture media.
- September 2017
:
Sartorius commenced a new facility center in Goettingen to manufacture laboratory instruments such as balances, ultrapure water systems, and moisture analyzers. - September 2016: Pall Corporation launched Pegasus Prime virus removal filters to provide retention of small viruses for critical manufacturing processes.
- April 2016:Charles River Laboratories acquired WIL Research, a premier provider of safety assessment, contract development, and manufacturing services.
Report Coverage
글로벌 바이러스 여과 시장 조사 보고서는 시장 점유율, 규모, 추세 및 기회에 대한 자세한 통찰력을 제공합니다. 이는 시장 변동에 영향을 미치는 동인 및 제한 사항의 역할을 간략하게 설명합니다. 또한, 미래 사업 투자 결정에 도움이 되도록 산업 환경, 시장 개요, 글로벌 비즈니스 분석을 자세히 설명했습니다. 최근 개발을 통해 제품 출시, 확장 및 인수를 언급하면서 지배적인 시장 참가자가 강조되었습니다.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The growth of the Virus filtration in market is attributed to the rising application of Virus filtration, launch of new virus filtration system, adoption of inorganic strategies by market players and rising demand for virus filtration technologies in biotechnology and pharmaceuticals.
The services segment is anticipated to witness the fastest growth rate of 14.9% during the forecast period, 2018 to 2025.
In 2017, the kits & reagents segment held a largest market share of 54.4% of the virus filtration market, by product. This segment is also expected to dominate the market in 2025 owing to increasing demand for kits and reagents in biotechnology and pharmaceutical companies.
The List of Companies
1. Merck KGaA
2. Sartorius AG
3. Danaher (Pall Corporation)
4. Thermo Fisher Scientific, Inc.
5. General Electric
6. Charles River
7. Wuxi Apptec
8. Lonza
9. Asahi Kesai Corporation
10. Clean Cells
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.